Wealthcare Capital Management’s Allergan plc AGN Stock Holding History

Wealthcare Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	271
2020 Q1	$0	Sell	1 -23	-96%	-$4.33K	﹤0.01%	699
2019 Q4	$5K	Buy	+24	New	+$4.33K	﹤0.01%	259
2018 Q1	–	Sell	-1	Closed	–	–	238
2017 Q4	$0	Hold	1	–	–	﹤0.01%	242
2017 Q3	$0	Hold	1	–	–	﹤0.01%	197
2017 Q2	$0	Hold	1	–	–	﹤0.01%	205
2017 Q1	$0	Hold	1	–	–	﹤0.01%	200
2016 Q4	$0	Hold	1	–	–	﹤0.01%	219
2016 Q3	$0	Buy	+1	New	+$244	﹤0.01%	210
2015 Q2	–	Sell	-54	Closed	-$16K	–	952
2015 Q1	$16K	Buy	+54	New	+$15.4K	﹤0.01%	441

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wealthcare Capital Management's AGN Position: Q2 2020 in Review

Wealthcare Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1 share.

Wealthcare Capital Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $16K in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Wealthcare Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Wealthcare Capital Management sold 1 Allergan plc share in Q2 2020.
Wealthcare Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
Wealthcare Capital Management's Allergan plc position peaked at $16K in Q1 2015.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wealthcare Capital Management's 13F filing for Q2 2020, filed 29 Jul 2020.